您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8420 处方药 8047 非处方药 267 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 美国
所属类别: 调节水、电解质药->电解质补充药
处方药:处方药
包装规格: 250毫升/袋
计价单位:
  点击放大  
生产厂家英文名:
Baxter Healthcare Corporation
该药品相关信息网址1:
https://www.rxlist.com/lactated-ringers-drug.htm
原产地英文商品名:
Lactated Ringers Injection 250mL/bag
原产地英文药品名:
Sodium chloride, potassium chloride, sodium lactate and calcium chloride
中文参考商品译名:
乳酸林格注射液 250毫升/袋
中文参考药品译名:
氯化钠,氯化钾,乳酸钠和氯化钙
原产地国家批准上市年份:
1971/03/22
英文适应病症1:
a source of water and electrolytes
临床试验期:
完成
中文适应病症参考翻译1:
水和电解质的来源
药品信息:

---------------------------------------------------------------
详细处方信息以本药内容附件PDF文件(201971016312913.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文乳酸林格注射液处方资料(仅供参考)

【英文名称】Lactated Ringers Injection

【适用证】

乳酸林格氏注射剂,USP被指示为水和电解质的来源或作为碱化剂。

【用法用量】

按照医生的指示。给药的剂量,速率和持续时间应个体化,并取决于使用指征,患者的年龄,体重,伴随治疗和患者的临床状况以及实验室测定。

VIAFLEX塑料容器中的所有注射均用于使用无菌和无热原设备进行静脉内给药。打开容器后,应立即使用内容物,不应存放以备后续输液。不要重新连接任何部分使用的容器。

当溶液和容器允许时,应在给药前肉眼检查肠外药物产品的颗粒物和变色。除非溶液清澈且密封完好,否则不要进行管理。

当添加乳酸林格氏注射剂USP时,必须使用无菌技术。添加添加剂后彻底混合溶液。不要存放含有添加剂的溶液。

添加剂可能与Lactated Ringer's Injection,USP不相容。与所有肠胃外溶液一样,添加剂与溶液的相容性必须在添加前通过检查可能的颜色变化和/或沉淀物,不溶性络合物或晶体的外观来评估。在添加物质或药物之前,确认它在水中是可溶的和/或稳定的,并且乳酸林格氏注射液,USP的pH范围是合适的。

必须参考添加药物的使用说明和其他相关文献。不应使用已知或确定为不相容的添加剂。

【禁忌】

对于其他含钙输液,同时给予头孢曲松和乳酸林格氏注射液,USP禁用于新生儿(≤28天龄),即使使用单独的输液管线(致命的头孢曲松钙盐沉淀风险) 新生儿的血液)。

对于超过28天的患者(包括成人),头孢曲松不得与静脉内含钙溶液同时给药,包括乳酸林格氏注射液,USP,通过相同的输液管线(例如,通过Y-连接器)。 如果使用相同的输注管线进行顺序给药,必须在用相容的液体输注之间彻底冲洗管线。

乳酸林格氏注射液,USP禁用于已知对乳酸钠过敏的患者。

【INDICATIONS AND USAGE】

Lactated Ringer’s Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent.

【DOSAGE AND ADMINISTRATION】

As directed by a physician. Dosage, rate and duration of administration are to be individualized and dependent upon the indication for use, the patient’s age, weight, concomitant treatment and clinical condition of the patient as well as laboratory determinations.

All injections in VIAFLEX plastic containers are intended for intravenous administration using sterile and nonpyrogenic equipment. After opening the container, the contents should be used immediately and should not be stored for a subsequent infusion. Do not reconnect any partially used containers.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Do not administer unless the solution is clear and seal is intact.

When making additions to Lactated Ringer’s Injection, USP, aseptic technique must be used. Mix the solution thoroughly when additives have been introduced. Do not store solutions containing additives.

Additives may be incompatible with Lactated Ringer’s Injection, USP. As with all parenteral solutions, compatibility of the additives with the solution must be assessed before addition, by checking for a possible color change and/or the appearance of precipitates, insoluble complexes, or crystals. Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of Lactated Ringer’s Injection, USP is appropriate.

The instructions for use of the medication to be added and other relevant literature must be consulted. Additives known or determined to be incompatible should not be used.

【CONTRAINDICATIONS】

As for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and Lactated Ringer’s Injection, USP is contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone calcium salt precipitation in the neonate’s bloodstream).

In patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including Lactated Ringer’s Injection, USP, through the same infusion line (e.g., via Y-connector). If the same infusion line is used for sequential administration, the line must be thoroughly flushed between infusions with a compatible fluid.

Lactated Ringer’s Injection, USP is contraindicated in patients with a known hypersensitivity to sodium lactate.

---------------------------------------------------------------
详细处方信息以本药内容附件PDF文件(201971016312913.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2019-5-29
附件:
201971016312913.pdf    

 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com